Advanced Instruments’ acquisition of Nova Biomedical completed

Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets.

The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in financing. The remainder of the enterprise value has been financed by external debt.

The combined company will now be named Nova Biomedical and be led by Advanced Instruments’ CEO Byron Selman. The combined company will be reflected in Investor’s reporting from the Interim Management Statement January-September 2025 onwards.